Safety Study of MGD009 in B7-H3-expressing Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Mesothelioma|Bladder Cancer|Melanoma|Squamous Cell Carcinoma of the Head and Neck|Non Small Cell Lung Cancer|Clear Cell Renal Cell Carcinoma|Ovarian Cancer|Thyroid Cancer|Breast Cancer|Pancreatic Cancer|Prostate Cancer|Colon Cancer|Soft Tissue Sarcoma
Interventions: BIOLOGICAL: MGD009
Sponsor: MacroGenics